Alexion Pharmaceuticals
0 sources
Financials
0000899866-21-000014Alexion Pharmaceuticals
Summary
Alexion Pharmaceuticals is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (1,426 views/month).[2]
Key Facts
- Alexion Pharmaceuticals is in the country of United States[3].
- Alexion Pharmaceuticals is in the country of US[4].
- Alexion Pharmaceuticals's instance of is recorded as business[5].
- Alexion Pharmaceuticals's instance of is recorded as enterprise[6].
- Alexion Pharmaceuticals's instance of is recorded as public company[7].
- Alexion Pharmaceuticals's headquarters location is recorded as Cheshire[8].
- Alexion Pharmaceuticals's child organization or unit is recorded as Alexion Pharma (Switzerland)[9].
- Alexion Pharmaceuticals's stock exchange is recorded as Nasdaq[10].
- Alexion Pharmaceuticals's industry is recorded as pharmaceutical industry[11].
- January 1, 1992 marks the founding of Alexion Pharmaceuticals[12].
- Alexion Pharmaceuticals's location of formation is recorded as Boston[13].
- Alexion Pharmaceuticals's parent organization or unit is recorded as AstraZeneca[14].
- Alexion Pharmaceuticals's official website is recorded as https://alexion.com/[15].
- Alexion Pharmaceuticals's official website is recorded as http://www.alexion.com[16].
- Alexion Pharmaceuticals's product or material produced is recorded as Soliris[17].
- Alexion Pharmaceuticals's product or material produced is recorded as Kanuma[18].
- Alexion Pharmaceuticals's product or material produced is recorded as ravulizumab[19].
- Alexion Pharmaceuticals's product or material produced is recorded as Strensiq[20].
- Alexion Pharmaceuticals's employees is recorded as {'amount': '+3837'}[21].
- Alexion Pharmaceuticals's employees is recorded as {'amount': '+2656'}[22].
- Alexion Pharmaceuticals's employees is recorded as {'amount': '+3082'}[23].
- Alexion Pharmaceuticals's legal form is recorded as Delaware corporation[24].
- Alexion Pharmaceuticals's legal form is recorded as XTIQ[25].
- Alexion Pharmaceuticals's short name is recorded as {'lang': 'en', 'text': 'Alexion'}[26].
- Alexion Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+6069900000'}[27].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): M1YXUUZR0EIMU8T0EM75[28]
-
Registered legal name: Alexion Pharmaceuticals, Inc.[29]
-
Legal jurisdiction: US-DE[30]
-
GLEIF entity category: GENERAL[31]
-
Legal form (ISO 20275 ELF): XTIQ[32]
-
Entity status: ACTIVE[33]
-
LEI registration status: LAPSED[34]
-
LEI first registered: 2012-06-06[35]
-
LEI last updated: 2023-08-04[36]
-
LEI next renewal: 2019-01-13[37]
-
Managing LOU: 5493001KJTIIGC8Y1R12[38]
-
Registration authority: RA000602[39]
-
Authority entity ID: 2286486[40]
-
Other names: Udec Pharmaceuticals, Inc.[41]
-
Conformity flag: NON_CONFORMING[42]
Body
Founding
January 1, 1992 marks the founding of Alexion Pharmaceuticals[12]. Its location of formation is recorded as Boston[13].
Identity
Alexion Pharmaceuticals's short name is recorded as {'lang': 'en', 'text': 'Alexion'}[26].
Operations
Alexion Pharmaceuticals's headquarters location is recorded as Cheshire[8]. Its parent organization or unit is recorded as AstraZeneca[14]. Its child organization or unit is recorded as Alexion Pharma (Switzerland)[9].
Industry
Alexion Pharmaceuticals's industry is recorded as pharmaceutical industry[11].
Ownership
Alexion Pharmaceuticals's stock exchange is recorded as Nasdaq[10]. Products include Soliris[17], Kanuma[18], ravulizumab[19], and Strensiq[20].
Why It Matters
Alexion Pharmaceuticals ranks in the top 4% of business entities by monthly Wikipedia readership (1,426 views/month).[2] It has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[43] It is known by 8 alternative names across languages and contexts.[44]